REGISTRATION RIGHTS AGREEMENT By and Between STRIDEBIO, INC. AND SAREPTA THERAPEUTICS, INC. Dated as of November 13, 2019Registration Rights Agreement • November 14th, 2019 • Sarepta Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 14th, 2019 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of November 13, 2019, by and among StrideBio, Inc., a Delaware corporation with its principal place of business at 5 Laboratory Drive, Suite 1200, Research Triangle Park, NC 27709 (“Investor”) and Sarepta Therapeutics, Inc. (the “Company”), a Delaware corporation with its principal place of business at 215 First Street, Suite 415, Cambridge, MA 02142.